Metapopulation dynamics and spatial heterogeneity in cancer
- PMID: 12351679
- PMCID: PMC130590
- DOI: 10.1073/pnas.202139299
Metapopulation dynamics and spatial heterogeneity in cancer
Abstract
With the advent of drugs targeting specific molecular defects in cancerous cells [Gorre, M. E., et al. (2001) Science 293, 876-880], it is important to understand the degree of genetic heterogeneity present in tumor cell populations and the rules that govern microdiversity in human cancer. Here, we first show that populations with different genotypes in genes influencing cell growth and programmed cell death coexist in advanced malignant tumors of the colon, exhibiting microsatellite instability. Detailed, physical mapping of the diverse populations shows them to be arranged in small, intermingling areas, resulting in a variegated pattern of diversity. Using computational modeling of the experimental data, we find that the coexistence between similar competitors is enhanced, instead of deterred, by spatial dynamics [Hanski, I. (1999) Metapopulation Dynamics (Oxford Univ. Press, New York)]. The model suggests a simple and plausible scenario for the generation of spatial heterogeneity during tumor progression. The emergence and persistence of the patterns of diversity encountered in the tumors can be generated without a need to invoke differences in mutation rates, neutrality of interactions, or separated time scales. We posit that the rules that apply to spatial ecology and explain the maintenance of diversity are also at work in tumors and may underlie tumor microheterogeneity.
Figures



Similar articles
-
Molecular mechanisms of inactivation of TGF-beta receptors during carcinogenesis.Cytokine Growth Factor Rev. 2000 Mar-Jun;11(1-2):159-68. doi: 10.1016/s1359-6101(99)00039-8. Cytokine Growth Factor Rev. 2000. PMID: 10708963 Review.
-
Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.PLoS One. 2016 Nov 11;11(11):e0166422. doi: 10.1371/journal.pone.0166422. eCollection 2016. PLoS One. 2016. PMID: 27835699 Free PMC article.
-
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects.Am J Pathol. 2001 Feb;158(2):537-42. doi: 10.1016/s0002-9440(10)63995-8. Am J Pathol. 2001. PMID: 11159190 Free PMC article.
-
Novel mutations in the polyadenine tract of the transforming growth factor beta type II receptor gene are found in a subpopulation of human pancreatic adenocarcinomas.Genes Chromosomes Cancer. 1998 Jun;22(2):138-44. doi: 10.1002/(sici)1098-2264(199806)22:2<138::aid-gcc8>3.0.co;2-y. Genes Chromosomes Cancer. 1998. PMID: 9598801
-
The type II transforming growth factor-beta receptor as a tumor-suppressor gene.Curr Opin Oncol. 1996 Jan;8(1):49-53. doi: 10.1097/00001622-199601000-00009. Curr Opin Oncol. 1996. PMID: 8868100 Review.
Cited by
-
A "conversion-deterioration-double mutation" theory for the evolution and progression of colorectal cancer.Cancer Med. 2022 Jul;11(13):2601-2611. doi: 10.1002/cam4.4637. Epub 2022 Mar 13. Cancer Med. 2022. PMID: 35285179 Free PMC article. Review.
-
Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration.Front Genet. 2022 May 13;13:884028. doi: 10.3389/fgene.2022.884028. eCollection 2022. Front Genet. 2022. PMID: 35646077 Free PMC article.
-
Mutational load distribution analysis yields metrics reflecting genetic instability during pancreatic carcinogenesis.Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4306-11. doi: 10.1073/pnas.0708250105. Epub 2008 Mar 12. Proc Natl Acad Sci U S A. 2008. PMID: 18337498 Free PMC article.
-
Tumor heterogeneity: causes and consequences.Biochim Biophys Acta. 2010 Jan;1805(1):105-17. doi: 10.1016/j.bbcan.2009.11.002. Epub 2009 Nov 18. Biochim Biophys Acta. 2010. PMID: 19931353 Free PMC article. Review.
-
Pathology to enhance precision medicine in oncology: lessons from landscape ecology.Adv Anat Pathol. 2015 Jul;22(4):267-72. doi: 10.1097/PAP.0000000000000078. Adv Anat Pathol. 2015. PMID: 26050264 Free PMC article. Review.
References
-
- Nowell P C. Science. 1976;194:23–28. - PubMed
-
- Waghorne C, Thomas M, Lagarde A, Kerbel R S, Breitman M-L. Cancer Res. 1988;48:6109–6114. - PubMed
-
- Fearon E-R, Vogelstein B. Cell. 1990;61:759–767. - PubMed
-
- Cavenee W-K, Scrable H-J, James C-D. Mutat Res. 1991;247:199–202. - PubMed
-
- Boland C-R, Sato J, Appelman H-D, Bresalier R-S, Feinberg A-P. Nat Med. 1995;1:902–909. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources